- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04961762
Navigator Program for Homeless Adults
Effect of a Navigator Program on Post-Hospital Outcomes for Homeless Adults: A Pragmatic Randomized Controlled Trial
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Katherine F Pridham, MSW
- Phone Number: 77354 416-864-6060
- Email: Katherine.Francombe@unityhealth.to
Study Contact Backup
- Name: Michael Liu, MPhil
- Email: mliu02@hms.harvard.edu
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5B1W8
- Recruiting
- St. Michael's Hospital
-
Contact:
- Katherine Francombe Pridham, MSW
- Phone Number: 77354 416-864-6060
- Email: Katherine.Francombe@unityhealth.to
-
Principal Investigator:
- Stephen W Hwang, MD, MPH
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18 years of age or older
- Have an unplanned admission for any medical cause to the General Internal Medicine service, any Medicine subspecialty service, the Cardiac Intensive Care Unit, and the Medical Surgical Intensive Care Unit
- Identified as being homeless at the time of admission or anytime during the index hospital admission. This includes patients who are: unsheltered (absolutely homeless and living on the streets or in places not intended for human habitation), emergency sheltered (staying in overnight shelters for people who are homeless, as well as shelters for those impacted by family violence), or provisionally accommodated (whose accommodation is temporary or lacks security of tenure).
Exclusion Criteria:
- Unable to provide informed consent to the study
- Previously received services from the Homeless Outreach Counsellor within 90 days of admission
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Navigator Program
In addition to receiving Standard Care, participants in the intervention arm will be assigned to a Homeless Outreach Counsellor.
The Homeless Outreach Counsellor will connect with the participant as soon as possible during the admission and will provide support during the hospital admission and for approximately 90 days after hospital discharge.
|
The main role of the Homeless Outreach Counsellor is to support continuity and comprehensiveness of care by helping participants follow their post-discharge plans and facilitating strong links with community-based health and social services.
The Homeless Outreach Counsellor also helps address specific needs of participants, develop comprehensive care plans with members of patient's multidisciplinary circle of care, and facilitate the transition of clients to long-term community-based health and social services.
|
No Intervention: Standard Care
Standard Care consists of support from Care Transition Facilitators who work with patients during their hospital stay to arrange discharge plans and make follow-up arrangements.
Care Transition Facilitators do not routinely work with patients after hospital discharge.
As part of the routine discharge process, the health care team provides patients with medical recommendations, appointments for follow-up care as needed, a written discharge summary, and prescriptions as needed.
If the patient has an identified primary care provider, a copy of the discharge summary is sent electronically to the primary care provider.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Follow-Up with Primary Care Provider (PCP)
Time Frame: Within 14 Days of Discharge
|
Occurrence of a follow-up visit with a PCP (family physician or nurse practitioner).
In-person encounters (e.g., ambulatory clinics, shelter clinics, and community health centers), virtual encounters (with video), and phone calls (without video) will be considered as follow-up visits.
These modes of PCP follow-up are consistent with those outlined by quality standards from Health Quality Ontario.
The investigators will ascertain PCP follow-up through both participant self-report at the 30-day interview and by contact with the PCP office.
Ascertainment will be based on the PCP office's report if the participant is unreachable, or by participant self-report if the PCP office is unreachable.
In the event of any discrepancy, the report of the PCP office will take precedence over participant self-report.
|
Within 14 Days of Discharge
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Composite All-Cause Hospital Readmission or Mortality
Time Frame: Within 30, 90, and 180 Days of Discharge
|
Hospital readmissions will be ascertained from the 30-day interview and administrative databases at ICES.
Mortality data will be collected from hospital charts, follow-up with community contacts, or administrative databases at ICES. (Hospital readmissions exclude elective or scheduled admissions, labor and delivery visits, and transfers between services [i.e., from medicine to psychiatry] within the hospital.)
|
Within 30, 90, and 180 Days of Discharge
|
Number of Days in Hospital
Time Frame: Within 30, 90, and 180 Days of Discharge
|
Number of days in hospital will be ascertained from the 30-day interview and administrative databases at ICES. (Days in hospital exclude elective or scheduled admissions and labor and delivery visits.)
|
Within 30, 90, and 180 Days of Discharge
|
Number of Emergency Department Visits
Time Frame: Within 30, 90, and 180 Days of Discharge
|
Number of emergency department visits will be ascertained from the 30-day interview and administrative databases at ICES.
|
Within 30, 90, and 180 Days of Discharge
|
Self-Reported Experience of Care Transition
Time Frame: At 30-Day Follow-Up Interview
|
Ascertained with the Care Transitions Measure-3 (CTM-3). The CTM-3 is an abbreviated version of the original CTM-15, which measures the extent to which the healthcare team accomplished essential care processes in preparing the patient for discharge and participating in post-hospital self-care activities. The CTM-3 consists of 3 items with a 4-point scale with responses ranging from "Strongly Disagree" (1) to "Strongly Agree" (4) to the following questions:
Items are scored by summing the responses and then linear transforming to a 0-100 range. Higher scores indicate better self-reported experience of care transition. |
At 30-Day Follow-Up Interview
|
Change in Competing Priorities
Time Frame: Baseline and At 30-Day Follow-Up Interview
|
Ascertained with the RAND Course of Homelessness Scale.
Developed specifically for the homeless population, the RAND scale is a 5-item index of self-reported difficulty in meeting the following subsistence needs over the past 30 days: frequency of difficulty in finding shelter, enough to eat, clothing, a place to wash, and a place to use the bathroom.
Possible responses to each item are never (1), rarely (2), sometimes (3), or usually (4) with total scores between 5-20.
Higher scores indicate more difficulty in meeting subsistence needs.
|
Baseline and At 30-Day Follow-Up Interview
|
Change in Health Status
Time Frame: Baseline and At 30-Day Follow-Up Interview
|
Ascertained with the EQ-5D-3L (EuroQol-5 Dimensions-3 Levels).
The EQ-5D-3L is a generic measure of health-related quality of life that has been widely used among the homeless population.
The EQ-5D-3L includes five 3-level items concerning mobility, self-care, usual activities, pain/discomfort, and anxiety/depression that are weighted to produce a single utility score between 0 and 1.
The Visual Analog Scale (VAS) of the EQ-5D-3L will also be included, which will allow participants to rate their overall health, mental health, and physical health from 0 to 100.
|
Baseline and At 30-Day Follow-Up Interview
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Leave Against Medical Advice
Time Frame: During Index Admission
|
Ascertained from discharge chart review
|
During Index Admission
|
Medication Adherence
Time Frame: At 30-Day Follow-Up Interview
|
Ascertained with the Morisky Medication Adherence Scale 8 (MMAS-8).
The MMAS-8 consists of 8 items, the first 7 of which are yes/no questions, and the last of which is a 5-point Likert-scale rating.
Total MMAS-8 scores can range from 0 to 8 and have been categorized into three levels of adherence: high adherence (score = 8), medium adherence (score of 6 to 8), and low adherence (score< 6).
|
At 30-Day Follow-Up Interview
|
Connection to Case Manager
Time Frame: At 30-Day Follow-Up Interview
|
Connection to a case manager after hospital discharge will be assessed only among participants who report no contact with a case manager in the 30 days prior to their baseline interview.
|
At 30-Day Follow-Up Interview
|
Attendance of non-PCP Health Care Appointment
Time Frame: Within 180 Days of Discharge
|
Non-PCP health care appointments are defined as appointments with any medical specialist or health care provider other than the participant's family physician or nurse practitioner.
Only appointments documented in the discharge summary will be assessed for attendance.
Attendance will be ascertained by contacting the health care provider.
|
Within 180 Days of Discharge
|
Time to Composite All-Cause Hospital Readmission or Mortality
Time Frame: Within 180 Days of Discharge
|
Time to all-cause hospital readmission or mortality is defined as the number of days from hospital discharge to the first all-cause hospital readmission or mortality during the 180-day observation period.
|
Within 180 Days of Discharge
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Stephen W Hwang, MD, MPH, Unity Health Toronto
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 21-058
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hospital Readmission
-
Luzerner KantonsspitalUniversity of LucerneCompletedHospital ReadmissionSwitzerland
-
Weill Medical College of Cornell UniversityMaimonides Medical Center; New York State Department of HealthCompletedHospital ReadmissionUnited States
-
Brigham and Women's HospitalHarvard Risk Management FoundationCompletedHospital ReadmissionUnited States
-
Boston Medical CenterCompletedReadmission, HospitalUnited States
-
Amsterdam UMC, location VUmcUnknownHospital ReadmissionDenmark, Netherlands, United Kingdom
-
Zealand University HospitalRegion Zealand; Roskilde Municipality; Køge Municipality; Stevns Municipality; Solrød... and other collaboratorsCompletedDischarge Planning | Readmission, HospitalDenmark
-
Radboud University Medical CenterNot yet recruitingReadmission | Inpatient Endoscopy Delay | Prolonged Hospital StayNetherlands
-
Universidad Autonoma de Nuevo LeonCompletedHospital Readmission | Newborn Morbidity | Newborn | Newborn Complication
-
Zealand University HospitalNykøbing Falster County Hospital; Region Zealand; Lolland Municipality; Guldborgsund... and other collaboratorsCompletedReadmission | Discharge Planning | Hospital | Frail Elderly PatientsDenmark
-
Wake Forest University Health SciencesCompletedHospital ReadmissionUnited States
Clinical Trials on Navigator Program
-
Stanford UniversityTerminatedGenital Neoplasms, Female | Breast Cancer | Gynecologic CancersUnited States
-
Children's Hospital of PhiladelphiaNational Institute of Mental Health (NIMH)Recruiting
-
University of CalgaryUniversity of AlbertaActive, not recruitingHypertension | Diabetes Mellitus, Type 2 | Chronic Kidney Diseases | Chronic Obstructive Pulmonary Disease | Asthma | Ischemic Heart Disease | Congestive Heart FailureCanada
-
University of CalgaryActive, not recruitingHypertension | Diabetes Mellitus, Type 2 | Chronic Kidney Diseases | Chronic Obstructive Pulmonary Disease | Asthma | Ischemic Heart Disease | Congestive Heart FailureCanada
-
University of CalgaryUniversity of AlbertaActive, not recruitingHypertension | Diabetes Mellitus, Type 2 | Chronic Kidney Diseases | Chronic Obstructive Pulmonary Disease | Asthma | Ischemic Heart Disease | Congestive Heart FailureCanada
-
University of California, Los AngelesNot yet recruitingSocial Isolation
-
University of Alabama at BirminghamNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Enrolling by invitationKidney DiseasesUnited States
-
Indiana UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingContraception | Health Care Utilization | Contraceptive UsageUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteRecruitingBrain CancerUnited States
-
Brigham and Women's HospitalPatient-Centered Outcomes Research InstituteActive, not recruitingObesity | OverweightUnited States